$RVTY News

Wolfe Research Assumes Revvity at Peer Perform

Research Tools & Consumables Stocks Q1 In Review: Revvity (NYSE:RVTY) Vs Peers

Revvity Stock: Analyst Estimates & Ratings

Revvity's (NYSE:RVTY) Conservative Accounting Might Explain Soft Earnings

The Top 5 Analyst Questions From Revvity’s Q1 Earnings Call

Revvity, Inc. (RVTY) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Revvity Receives FDA Clearance for Total Testosterone Assay Enabling Comprehensive Automated Testosterone Testing Solution

3 Cash-Producing Stocks That Concern Us

Is Revvity’s (RVTY) China Exit and EPS Reset Quietly Rewriting Its Portfolio Strategy?

Barclays Maintains Equal-Weight on Revvity, Raises Price Target to $105

JP Morgan Maintains Neutral on Revvity, Lowers Price Target to $90

TD Cowen Maintains Buy on Revvity, Raises Price Target to $120

Stifel Maintains Hold on Revvity, Lowers Price Target to $100

Revvity, Inc. Q1 2026 Earnings Call Summary

Revvity (RVTY) Q1 2026 Earnings Transcript

Compared to Estimates, Revvity (RVTY) Q1 Earnings: A Look at Key Metrics

Revvity Q1 Earnings Call Highlights

Revvity (NYSE:RVTY) Beats Q1 CY2026 Sales Expectations

Revvity (RVTY) Q1 Earnings and Revenues Top Estimates

Revvity (NYSE:RVTY) Q1 2026 Earnings Beat Sends Shares Higher Despite Revenue Miss